Stago UK Ltd
Moulden Way
COMPANY INFORMATION
Stago’s objective is to improve the health of as many people as possible by offering powerful biotechnology solutions for blood-based diagnostics.
We take a lean, confidence-building approach to digital connectivity – from our latest Coag.One middleware to our cyber-secure Connect.One capability for enhanced engineering and remote problem-solving. Customers also benefit from the additional features of our external and internal quality control systems, to monitor system performance and support UKAS accreditation.
Almost one quarter of NHS labs now rely on our robust, highly sensitive and specific assays, whilst automated algorithms aid in the diagnosis of complex disease, helping to rule out potentially costly and unnecessary procedures.
From high throughput instruments to more compact models, Stago is increasingly the provider of first choice for haematology labs. Whether in stand-alone or multi-site network configurations, our highly efficient, instruments have minimal hands-on requirement and align with ease to existing automated systems.
LATEST STORIES
PRODUCTS AND SERVICES
Latest Issues
Association for Molecular Pathology (AMP) 2024 Annual Meeting & Expo
Hyatt Regency, Vancouver, Canada
19-23 November, 2024
Advances in Transfusion Medicine 2024 – Joint RCPath & SHOT Symposium
Online
20-21 November, 2024
11th Digital Pathology & AI Congress: Europe
Hilton London Metropole, 255 Edgware Road, London, W2 1JU
11-12 December, 2024
Microbiology Society Annual Conference 2025
Liverpool Arena and Convention Centre
31 March - 3 April, 2025
BSMT Annual Microbiology Conference
RAF Museum, Hendon, London NW9 5LL
15 May, 2025
[email protected]